{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:39:49Z","timestamp":1791722389070,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eclinm.2024.102532","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T23:47:48Z","timestamp":1710892068000},"page":"102532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"70","author":[{"given":"Alison","family":"Erlwanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-9852","authenticated-orcid":false,"given":"Isabelle","family":"Rocroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-7457","authenticated-orcid":false,"given":"Joris","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102532_bib1","series-title":"Global HIV & AIDS statistics","author":"UNAIDS","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102532_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001608","article-title":"Incident HIV during pregnancy and postpartum and risk of Mother-to-child HIV transmission: a systematic review and meta-analysis","volume":"11","author":"Drake","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2024.102532_bib3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2024.102532_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101368","article-title":"Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: a systematic review and meta-analysis","volume":"46","author":"Cowdell","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102532_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s43856-023-00331-8","article-title":"Adverse perinatal outcomes attributable to HIV in sub-Saharan Africa from 1990 to 2020: systematic review and meta-analyses","volume":"3","author":"Murray","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.eclinm.2024.102532_bib6","author":"United Nations"},{"key":"10.1016\/j.eclinm.2024.102532_bib7","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102532_bib8","doi-asserted-by":"crossref","first-page":"j3677","DOI":"10.1136\/bmj.j3677","article-title":"Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets","volume":"358","author":"Lee","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2024.102532_bib9","series-title":"Survive and thrive: transforming care for every small and sick newborn (Global Report)","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.eclinm.2024.102532_bib10","series-title":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.eclinm.2024.102532_bib11","series-title":"Guidelines on long-acting injectable cabotegravir for HIV prevention","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102532_bib12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2024.102532_bib13","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102532_bib14","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1016\/S2352-3018(21)00280-0","article-title":"Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap","volume":"9","author":"Joseph Davey","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2024.102532_bib15","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","article-title":"Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study","volume":"8","author":"Nel","year":"2021","journal-title":"Lancet HIV"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2024.102532_bib16","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAI.0000000000001063","article-title":"Cost-effectiveness of pre-exposure HIV prophylaxis during pregnancy and breastfeeding in sub-saharan Africa","volume":"72","author":"Price","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2024.102532_bib17","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S2352-3018(20)30102-8","article-title":"Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework","volume":"7","author":"Pintye","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2024.102532_bib18","article-title":"Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?","volume":"23","author":"Joseph Davey","year":"2020","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.eclinm.2024.102532_bib19","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/S2352-3018(22)00006-6","article-title":"Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?","volume":"9","author":"Schmidt","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2024.102532_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1071\/SH18067","article-title":"Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding","volume":"15","author":"Davies","year":"2018","journal-title":"Sex Health"},{"key":"10.1016\/j.eclinm.2024.102532_bib21","author":"Higgins"},{"key":"10.1016\/j.eclinm.2024.102532_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2024.102532_bib23","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102532_bib24","series-title":"HIV research for prevention conference (P07.20)","article-title":"Implementation of a safer conception program for HIV-affected men and women in Uganda","author":"Matthews","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102532_bib25","series-title":"HIV research for prevention conference (P07.13)","article-title":"Pregnancy incidence and outcomes among women using dapivirine vaginal ring for HIV prevention in a phase III clinical trial in South western Uganda","author":"Kusemererwa","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102532_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QAI.0000000000000413","article-title":"Pregnancy and contraceptive use among women participating in the FEM-PrEP trial","volume":"68","author":"Callahan","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2024.102532_bib27","series-title":"International AIDS conference","article-title":"Pregnancy incidence and outcomes in women receiving tenofovir-based PrEP in the VOICE trial","author":"Bunge","year":"2015"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102532_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0000000000003312","article-title":"DELIVER: a safety study of a dapivirine vaginal ring and oral PrEP for the prevention of HIV\u00a0during pregnancy","volume":"95","author":"Bunge","year":"2024","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2024.102532_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0000000000001861","article-title":"Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy","volume":"79","author":"Makanani","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2024.102532_bib30","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2352-3018(22)00369-1","article-title":"Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial","volume":"10","author":"Moodley","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.eclinm.2024.102532_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.2014.8735","article-title":"Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial","volume":"312","author":"Mugo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102532_bib32","series-title":"Topics in antiviral medicine","first-page":"137","article-title":"Pregnancy and birth outcomes in PrEP-exposed & unexposed pregnant South African women","author":"Davey","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102532_bib33","article-title":"Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya","volume":"22","author":"Dettinger","year":"2019","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.eclinm.2024.102532_bib34","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/QAD.0000000000001867","article-title":"Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention","volume":"32","author":"Heffron","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2024.102532_bib35","series-title":"Conference on retroviruses and opportunistic infections (CROI)","article-title":"Prenatal PrEP exposure and longitudinal birth outcomes in Kenya","author":"Dettinger","year":"2020"},{"key":"10.1016\/j.eclinm.2024.102532_bib36","series-title":"Immediate or deferred pre-exposure prophylaxis for HIV prevention: safe options for pregnant and lactating women an open-label randomised control study","author":"Moodley","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102532_bib37","article-title":"Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa","volume":"25","author":"Joseph Davey","year":"2022","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.eclinm.2024.102532_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025122","article-title":"PrEP implementation for mothers in antenatal care (PrIMA): study protocol of a cluster randomised trial","volume":"9","author":"Dettinger","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2024.102532_bib39","author":"John-Stewart"},{"key":"10.1016\/j.eclinm.2024.102532_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001359","article-title":"Safety of tenofovir disoproxil fumarate-based antiretroviral therapy regimens in pregnancy for HIV-infected women and their infants: a systematic review and meta-analysis","volume":"76","author":"Nachega","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eclinm.2024.102532_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019022","article-title":"Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis","volume":"7","author":"Siemieniuk","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2024.102532_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.24927","article-title":"Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women-an updated systematic review and meta-analysis","volume":"90","author":"Ma","year":"2018","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.eclinm.2024.102532_bib43","article-title":"Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?","volume":"22","author":"Fairlie","year":"2019","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.eclinm.2024.102532_bib44","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/QAD.0000000000001922","article-title":"Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis","volume":"32","author":"Pyra","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.eclinm.2024.102532_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijgo.2015.10.023","article-title":"A\u00a0systematic review and meta-analysis of intimate partner violence during pregnancy and selected birth outcomes","volume":"133","author":"Hill","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.eclinm.2024.102532_bib46","article-title":"Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis","volume":"9","author":"Qin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2024.102532_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejogrb.2006.02.001","article-title":"Do screening-preventative interventions in asymptomatic pregnancies reduce the risk of preterm delivery--a critical appraisal of the literature","volume":"127","author":"Varma","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102532_bib48","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/S1473-3099(22)00687-9","article-title":"Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced women","volume":"23","author":"Eke","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:38:02Z","timestamp":1751524682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"alternative-id":["S2589537024001111"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102532","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102532"}}